Evidence map›Paper›PMID 24458535›Full record

ArticleJournal of materials science. Materials in medicine2014

Bioactive nanocomposite PLDL/nano-hydroxyapatite electrospun membranes for bone tissue engineering.

Izabella Rajzer, Elżbieta Menaszek, Ryszard Kwiatkowski, Wojciech Chrzanowski

Abstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Novel hybrid materials for preparation of bone tissue engineering scaffolds.Journal of materials science. Materials in medicine · 2015
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Izabella RajzerDivision of Materials Engineering, Department of Mechanical Engineering Fundamentals, ATH University of Bielsko-Biala, Willowa 2 Street, 43-309, Bielsko-Biała, Poland, irajzer@ath.bielsko.pl.
Elżbieta Menaszek
Ryszard Kwiatkowski
Wojciech Chrzanowski

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New nanocomposite membranes with high bioactivity were fabricated using the electrospinning. These nanocomposites combine a degradable polymer poly(L/DL)-lactide and bone cell signaling carbonate nano-hydroxyapatite (n-HAp). Chemical and physical characterization of the membranes using scanning electron microscopy, Fourier transform infrared spectroscopy and the wide angle X-ray diffraction evidenced that nanoparticles were successfully incorporated into the fibers and membrane structure. The incorporation of the n-HAp into the structure increased significantly the mineralization of the membrane in vitro. It has been demonstrated that after a 3-day incubation of composite membrane in the Simulated Body Fluid a continuous compact apatite layer was formed. In vitro experiments demonstrated that the incorporation of n-HAp significantly improved cell attachment, upregulated cells proliferation and stimulated cell differentiation quantified using Alkaline Phosphatase and OsteoImage tests. In conclusion, the results demonstrated that the addition of n-HAp provided chemical cues that were a key factor that regulated osteoblastic differentiation.

Indexed as

Membranes, ArtificialTissue ScaffoldsBiocompatible MaterialsBody FluidsBone DevelopmentBone SubstitutesCell DifferentiationCell LineCells, CulturedCell SurvivalDurapatiteElectroplatingEquipment DesignHumansMaterials TestingNanocompositesBiocompatible MaterialsBone SubstitutesDurapatiteMembranes, Artificial

Identifiers

PMID24458535
PMCPMC3984671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.